This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Pros And Cons Of Animal Testing - Latest Research In Ongoing Debate

Nonpartisan ProCon.org Launches Its New Website on the Animal Testing Debate

SANTA MONICA, Calif., Oct. 22, 2013 /PRNewswire-USNewswire/ -- An estimated 26 million animals, including cats, rats, dogs, mice and marmosets, are used every year in the United States for scientific and commercial testing.

ProCon.org, a nonpartisan research organization devoted to critical thinking on controversial topics, debuts its 49th issue website, http://animal-testing.procon.org, and delves deeply into the pros and cons of animal testing using the latest studies, perspectives, and facts.

Proponents of animal testing say that it has enabled the development of many life-saving treatments for both humans and animals, that there is no alternative method for researching a complete living organism, and that strict regulations prevent the mistreatment of animals in laboratories.

Opponents of animal testing say that it is cruel and inhumane to experiment on animals, that alternative methods available to researchers can replace animal testing, and that animals are so different from human beings that research on animals often yields irrelevant results.

In response to the website's core question, "Should animals be used for scientific or commercial testing?" ProCon.org presents sourced pros and cons, a historical background section, videos, images, over 100 footnotes and sources, and Did You Know? facts including (sources available online):

* 95% of animals used in experiments are not protected by the federal Animal Welfare Act (AWA), which excludes birds, rats and mice bred for research, and cold-blooded animals such as reptiles and most fish.

* A 2011 poll of nearly 1,000 biomedical scientists conducted by the science journal Nature found that more than 90% "agreed that the use of animals in research is essential."

* Chimpanzees share 99% of their DNA with humans, and mice are 98% genetically similar to humans. The United States and Gabon are the only two countries that allow experimentation on chimpanzees.

"We tackled this classic debate because our readers asked us to, because it affects many people and animals, and frankly because many existing sources have a stake in the discussion," explains ProCon.org President & Managing Editor Kamy Akhavan. "We have no stake in the issue other than to stimulate critical thinking by presenting the best arguments on both sides."

For pros, cons, and related research on animal testing, visit http://animal-testing.procon.org  

About Us

ProCon.org (online at www.procon.org) is a 501(c)(3) nonprofit public charity whose mission is promoting critical thinking, education, and informed citizenship.  Information is presented on 48 different ProCon.org issue websites in subjects ranging from Obamacare, alternative energy, and medical marijuana to the death penalty, illegal immigration, and gay marriage.

ProCon.org websites are free of charge and require no registration.  The websites have been cited dozens of times by the governments of 11 countries (including the United States where 27 states and nine federal agencies cite ProCon.org), and used by teachers, librarians, and educators in over 4,100 schools in all 50 US states and 58 countries.

ProCon.org had over 15.7 million unique readers in 2012 and more than 2 billion hits since its inception in 2004.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs